• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米颗粒蛋白冠中的独特蛋白质代表了内源性靶向的有前途的靶标 - 第二部分:体外和体内动力学研究。

Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting - Part II: In vitro and in vivo Kinetics Study.

机构信息

Pharmaceutical Technology Department, Faculty of Pharmacy and Biotechnology, German University in Cairo (GUC), New Cairo City, Egypt.

Biochemistry Department, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Giza, Egypt.

出版信息

Int J Nanomedicine. 2020 Nov 30;15:9539-9556. doi: 10.2147/IJN.S273721. eCollection 2020.

DOI:10.2147/IJN.S273721
PMID:33299308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7721286/
Abstract

INTRODUCTION

Nanoparticles (NPs), upon introduction to the biological systems, become wrapped by serum and cellular proteins constituting the protein corona (PC). This PC contributes largely to the NPs' interaction with the biological systems and their subsequent functions. On the one hand, PC can decrease the efficiency of targeting by directing the NPs to the reticuloendothelial system (RES) or by masking the active targeting moieties and decreasing their ability to bind to their target receptors. On the other hand, some components of PC have offered hopes for achieving endogenous targeting.

METHODS

In this study, we aimed at the investigation of the role of the PC in determining the behavior of cRGDyk peptide-unconjugated and -conjugated NPs (uNPs and cNPs) exhibiting different physicochemical properties and their interaction with melanoma on in vitro and in vivo levels. Mathematical modeling has been utilized to understand the kinetics of the interaction of NPs with the tumor cells and different organs, respectively.

RESULTS

Endocytosis and exocytosis were reported to occur simultaneously for the utilized NPs. The balance was largely dependent on the NPs' physicochemical properties and the role of the PC. In addition, distinct proteins present in the PC (illustrated in the results of the PC analysis in part I) have also determined the patterns of the NPs' distribution in different organs and tissues of the vascular system, the RES system and the target tumot tissue. Vitronectin (VN) was found to mediate higher accumulation in integrin receptor-expressing melanoma cells, while complement 3 protein (C3) and clusterin (CLU), as an opsonin and dysopsonin, respectively, regulated the balance between the RES uptake and blood circulation.

DISCUSSION

PC, if properly modulated by tuning NPs' physicochemical properties, can serve as a potential venue for optimum utilization of NPs in cancer therapy.

摘要

简介

纳米粒子(NPs)进入生物系统后,会被血清和细胞蛋白包裹,形成蛋白质冠(PC)。PC 极大地影响了 NPs 与生物系统的相互作用及其后续功能。一方面,PC 可以通过将 NPs 导向网状内皮系统(RES)或掩盖主动靶向部分,降低其与靶受体结合的能力,从而降低靶向效率。另一方面,PC 的一些成分为实现内源性靶向提供了希望。

方法

在这项研究中,我们旨在研究 PC 在决定 cRGDyk 肽未缀合和缀合 NPs(uNPs 和 cNPs)行为中的作用,这些 NPs 表现出不同的物理化学性质,并在体外和体内水平上研究其与黑色素瘤的相互作用。数学模型被用于理解 NPs 与肿瘤细胞和不同器官相互作用的动力学。

结果

据报道,内吞作用和外排作用同时发生在所用的 NPs 上。这种平衡在很大程度上取决于 NPs 的物理化学性质和 PC 的作用。此外,PC 中存在的不同蛋白质(在第一部分的 PC 分析结果中说明)也决定了 NPs 在血管系统、RES 系统和靶肿瘤组织的不同器官和组织中的分布模式。纤连蛋白(VN)被发现介导整合素受体表达的黑色素瘤细胞中更高的积累,而补体 3 蛋白(C3)和簇蛋白(CLU)分别作为调理素和调理素,调节 RES 摄取和血液循环之间的平衡。

讨论

如果通过调整 NPs 的物理化学性质来适当调节 PC,可以为在癌症治疗中最佳利用 NPs 提供潜在的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e944/7721286/e14a1ae7b1a3/IJN-15-9539-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e944/7721286/aba12872f913/IJN-15-9539-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e944/7721286/e14a1ae7b1a3/IJN-15-9539-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e944/7721286/aba12872f913/IJN-15-9539-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e944/7721286/e14a1ae7b1a3/IJN-15-9539-g0002.jpg

相似文献

1
Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting - Part II: In vitro and in vivo Kinetics Study.纳米颗粒蛋白冠中的独特蛋白质代表了内源性靶向的有前途的靶标 - 第二部分:体外和体内动力学研究。
Int J Nanomedicine. 2020 Nov 30;15:9539-9556. doi: 10.2147/IJN.S273721. eCollection 2020.
2
Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting - Part I: In vitro Release and Intracellular Uptake Perspective.纳米颗粒蛋白冠中的独特蛋白质代表了内源性靶向的有前途的途径——第 I 部分:体外释放和细胞内摄取视角。
Int J Nanomedicine. 2020 Nov 10;15:8845-8862. doi: 10.2147/IJN.S273713. eCollection 2020.
3
Synthetic and biological identities of polymeric nanoparticles influencing the cellular delivery: An immunological link.聚合物纳米粒子的合成和生物学特性影响细胞传递:免疫联系。
J Colloid Interface Sci. 2019 Nov 15;556:476-491. doi: 10.1016/j.jcis.2019.08.060. Epub 2019 Aug 16.
4
Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells.动态流动环境对纳米颗粒-蛋白质冠层的影响:从蛋白质模式到癌细胞摄取
Colloids Surf B Biointerfaces. 2017 May 1;153:263-271. doi: 10.1016/j.colsurfb.2017.02.037. Epub 2017 Feb 28.
5
The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.纳米颗粒-蛋白冠复合物与细胞的相互作用及其对细胞的毒性作用。
Chemosphere. 2020 Apr;245:125624. doi: 10.1016/j.chemosphere.2019.125624. Epub 2019 Dec 12.
6
Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.理解影响基于壳聚糖的纳米粒子-蛋白冠相互作用和药物传递应用的因素。
Molecules. 2020 Oct 16;25(20):4758. doi: 10.3390/molecules25204758.
7
How eluents define proteomic fingerprinting of protein corona on nanoparticles.洗脱液如何定义纳米颗粒上蛋白质冠的蛋白质组指纹图谱。
J Colloid Interface Sci. 2023 Oct 15;648:497-510. doi: 10.1016/j.jcis.2023.05.045. Epub 2023 May 10.
8
Potential clinical applications of the personalized, disease-specific protein corona on nanoparticles.个性化、疾病特异性蛋白冠在纳米颗粒上的潜在临床应用。
Clin Chim Acta. 2020 Feb;501:102-111. doi: 10.1016/j.cca.2019.10.027. Epub 2019 Oct 31.
9
Engineering the protein corona: Strategies, effects, and future directions in nanoparticle therapeutics.工程化蛋白冠:纳米颗粒治疗学中的策略、影响和未来方向。
Biomed Pharmacother. 2024 Jun;175:116627. doi: 10.1016/j.biopha.2024.116627. Epub 2024 Apr 22.
10
Impact of Surface-Engineered ZnO Nanoparticles on Protein Corona Configuration and Their Interactions With Biological System.表面工程 ZnO 纳米粒子对蛋白冠构象的影响及其与生物体系的相互作用。
J Pharm Sci. 2019 May;108(5):1872-1889. doi: 10.1016/j.xphs.2018.12.021. Epub 2019 Jan 5.

引用本文的文献

1
Serum heat inactivation diminishes ApoE-mediated uptake of D-Lin-MC3-DMA lipid nanoparticles.血清热灭活会减少载脂蛋白E介导的D-Lin-MC3-DMA脂质纳米颗粒的摄取。
Beilstein J Nanotechnol. 2025 May 30;16:740-748. doi: 10.3762/bjnano.16.57. eCollection 2025.
2
Glycopolymeric Nanoparticles Enrich Less Immunogenic Protein Coronas, Reduce Mononuclear Phagocyte Clearance, and Improve Tumor Delivery Compared to PEGylated Nanoparticles.糖聚合物纳米粒子比聚乙二醇化纳米粒子富集免疫原性较低的蛋白冠,减少单核吞噬细胞清除,提高肿瘤递呈。
ACS Nano. 2024 Nov 5;18(44):30540-30560. doi: 10.1021/acsnano.4c08922. Epub 2024 Oct 22.
3

本文引用的文献

1
Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting - Part I: In vitro Release and Intracellular Uptake Perspective.纳米颗粒蛋白冠中的独特蛋白质代表了内源性靶向的有前途的途径——第 I 部分:体外释放和细胞内摄取视角。
Int J Nanomedicine. 2020 Nov 10;15:8845-8862. doi: 10.2147/IJN.S273713. eCollection 2020.
2
RGD peptide-mediated liposomal curcumin targeted delivery to breast cancer cells.RGD 肽介导的脂质体姜黄素靶向递送至乳腺癌细胞。
J Biomater Appl. 2021 Feb;35(7):743-753. doi: 10.1177/0885328220949367. Epub 2020 Aug 17.
3
A Systematic comparison of in vitro cell uptake and in vivo biodistribution for three classes of gold nanoparticles with saturated PEG coatings.
Unraveling the impact of different liposomal formulations on the plasma protein corona composition might give hints on the targeting capability of nanoparticles.
揭示不同脂质体制剂对血浆蛋白冠层组成的影响可能会为纳米颗粒的靶向能力提供线索。
Nanoscale Adv. 2024 Jul 2;6(17):4434-4449. doi: 10.1039/d4na00345d. eCollection 2024 Aug 20.
4
Transforming Healthcare with Nanomedicine: A SWOT Analysis of Drug Delivery Innovation.纳米医学引领医疗变革:药物输送创新的 SWOT 分析。
Drug Des Devel Ther. 2024 Aug 5;18:3499-3521. doi: 10.2147/DDDT.S470210. eCollection 2024.
5
Multitarget, multiagent PLGA nanoparticles for simultaneous tumor eradication and TME remodeling in a melanoma mouse model.载多靶向、多组分药物的 PLGA 纳米粒在黑色素瘤小鼠模型中同步实现肿瘤消除和 TME 重塑。
Drug Deliv Transl Res. 2024 Feb;14(2):491-509. doi: 10.1007/s13346-023-01413-9. Epub 2023 Aug 23.
6
Macromolecules Absorbed from Influenza Infection-Based Sera Modulate the Cellular Uptake of Polymeric Nanoparticles.从流感感染血清中吸收的大分子调节聚合物纳米颗粒的细胞摄取。
Biomimetics (Basel). 2022 Nov 30;7(4):219. doi: 10.3390/biomimetics7040219.
7
Protein corona: Friend or foe? Co-opting serum proteins for nanoparticle delivery.蛋白质冠:是敌是友?利用血清蛋白进行纳米颗粒递药。
Adv Drug Deliv Rev. 2023 Jan;192:114635. doi: 10.1016/j.addr.2022.114635. Epub 2022 Nov 26.
8
Trident Nano-Indexing the Proteomics Table: Next-Version Clustering of Iron Carbide NPs and Protein Corona.三叉戟纳米索引蛋白质组学表:下一代碳化铁纳米粒子和蛋白质电晕的聚类。
Molecules. 2022 Sep 6;27(18):5754. doi: 10.3390/molecules27185754.
9
Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation.药物靶向与纳米医学:从肝脏靶向中汲取的经验教训及药物创新机遇
Pharmaceutics. 2022 Jan 17;14(1):217. doi: 10.3390/pharmaceutics14010217.
10
Silver Nanostructures: Limited Sensitivity of Detection, Toxicity and Anti-Inflammation Effects.银纳米结构:检测灵敏度有限、毒性及抗炎作用
Int J Mol Sci. 2021 Sep 14;22(18):9928. doi: 10.3390/ijms22189928.
三种具有饱和 PEG 涂层的金纳米粒子的体外细胞摄取和体内生物分布的系统比较。
PLoS One. 2020 Jul 2;15(7):e0234916. doi: 10.1371/journal.pone.0234916. eCollection 2020.
4
Exploitation of nanoparticle-protein corona for emerging therapeutic and diagnostic applications.利用纳米颗粒-蛋白质冠层实现新兴的治疗和诊断应用。
J Mater Chem B. 2016 Jul 7;4(25):4376-4381. doi: 10.1039/c6tb01095d. Epub 2016 Jun 6.
5
Lipid-PLGA hybrid nanoparticles of paclitaxel: Preparation, characterization, in vitro and in vivo evaluation.紫杉醇脂质 -PLGA 杂化纳米粒的制备、表征、体外与体内评价。
Mater Sci Eng C Mater Biol Appl. 2020 Apr;109:110576. doi: 10.1016/j.msec.2019.110576. Epub 2019 Dec 21.
6
Imaging-assisted anticancer nanotherapy.影像辅助抗癌纳米治疗。
Theranostics. 2020 Jan 1;10(3):956-967. doi: 10.7150/thno.38288. eCollection 2020.
7
The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.纳米颗粒-蛋白冠复合物与细胞的相互作用及其对细胞的毒性作用。
Chemosphere. 2020 Apr;245:125624. doi: 10.1016/j.chemosphere.2019.125624. Epub 2019 Dec 12.
8
Recent progress in biomedical applications of RGD-based ligand: From precise cancer theranostics to biomaterial engineering: A systematic review.基于 RGD 配体的生物医学应用的最新进展:从精准癌症治疗到生物材料工程:系统综述。
J Biomed Mater Res A. 2020 Apr;108(4):839-850. doi: 10.1002/jbm.a.36862. Epub 2019 Dec 30.
9
Lipid and PLGA Microparticles for Sustained Delivery of Protein and Peptide Drugs.用于蛋白质和肽类药物持续递送的脂质和聚乳酸-羟基乙酸共聚物微粒
Pharm Nanotechnol. 2020;8(1):22-32. doi: 10.2174/2211738507666191029160944.
10
Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles.冠状病毒组成可能会影响细胞内化纳米颗粒的机制。
ACS Nano. 2019 Oct 22;13(10):11107-11121. doi: 10.1021/acsnano.9b03824. Epub 2019 Sep 23.